[1]叶定伟,朱耀.中国前列腺癌的流行病学概述和启示[J].中华外科杂志,2015,53(4):249 [2]Helfand B, Kearns J, Conran C, et al. Clinical validity and utility of genetic risk scores in prostate cancer[J].Asian J Androl,2016,18(4):509 [3]赵阳,彭景,张雪宁. MR分子探针与分子成像的研究进展[J].国际医学放射学杂志,2015,38(5):455 [4]Chu M, Shao Y, Peng J, et al. Near-infrared laser light mediated cancer therapy by photothermal effect of Fe3O4 magnetic nanoparticles[J].Biomaterials, 2013,34 (16):4078 [5]Yuan G, Yuan Y, Xu K, et al. Biocompatible PEGylated Fe?O? nanoparticles as photothermal agents for near-infrared light modulated cancer therapy[J].Int J Mol Sci,2014,15(10):18776 [6]Elshafae S, Hassan B, Supsavhad W, et al. Gastrin-releasing peptide receptor (GRPr) promotes EMT, growth, and invasion in canine prostate cancer[J].Prostate, 2016,76(9):796 [7]Xuan S, Wang Y J, Yu J C, et al. Tuning the grain size and particle size of superparamagnetic Fe3O4 microparticles[J].Chem Mater,2009,21(21):5079 [8]Jiang W, Xie H, Ghoorah D, et al.Conjugation of functionalized SPIONs with transferrin for targeting and imaging brain glial tumors in rat model[J].PLoS One,2012,7(5):e37376 [9]Li Y, Chen Z, Li F, et al. Preparation and in vitro studies of MRI-specific superparamagnetic Iron oxide antiGPC3 probe for hepatocellular carcinoma[J].Int J Nanomedicine,2012,7(9):4593 [10]Zhou Z, Lu Z. Gadolinium-based contrast agents for magnetic resonance cancer imaging[J].Wiley Interdiscip Rev Nanomed Nanobiotechnol,2013,5(1):1 [11]Zhou Z, Sun Y, Shen J, et al. Iron/Iron oxide core/shell nanoparticles for magnetic targeting MRI and near-infrared photothermal therapy[J].Biomaterials, 2014,35 (26):7470 [12]Li X, Takashima M, Yuba E, et al. PEGylated PAMAM dendrimer-doxorubicin conjugate-hybridized Gold nanorod for combined photothermal-chemotherapy[J]. Biomaterials,2014,35(24):6576 [13]Tao Y, Ju E, Liu Z, et al. Engineered, self-assembled near-infrared photothermal agents for combined tumor immunotherapy and chemo-photothermal therapy[J]. Biomaterials,2014,35(24):6646 [14]Bai J, Liu Y, Jiang X. Multifunctional PEG-GO/CuS nanocomposites for near-infrared chemo-photothermal therapy[J].Biomaterials,2014,35(22):5805
[1]魏强,齐灿,罗飞,等.转移性去势抵抗性前列腺癌患者多西他赛化疗的预后分析[J].天津医科大学学报,2013,19(05):390.
[2]杨帮东,姜行康,齐 灿,等.尿液中PCA3评分对前列腺癌早期诊断的临床意义[J].天津医科大学学报,2013,19(06):487.
YANG Bang-dong,JIANG Xing-kang,QI Can,et al.Clinical significance of urinary PCA3 score to diagnose prostate cancer[J].Journal of Tianjin Medical University,2013,19(02):487.
[3]刘利维,刘春雨. MicroRNAs 与前列腺癌的表观遗传学研究进展[J].天津医科大学学报,2014,20(01):74.
[4]王 超,余泉峰,徐 勇,等.经直肠超声造影诊断前列腺癌的临床分析[J].天津医科大学学报,2014,20(05):375.
WANG Chao,YU Quan-feng,XU Yong,et al.Clinical analysis of contrast-enhanced transrectal ultrasonography for the diagnosis of prostate cancer[J].Journal of Tianjin Medical University,2014,20(02):375.
[5]张晓会,张志宏,徐 勇,等.合并症对局限性或局部晚期前列腺癌患者早期生存的影响[J].天津医科大学学报,2014,20(05):379.
ZHANG Xiao-hui,ZHANG Zhi-hong,XU Yong,et al. Influence of complications on early survival of patients with localized or locally advanced prostate cancer[J].Journal of Tianjin Medical University,2014,20(02):379.
[6]盛 镔,张 蒙,马鹏德,等.核糖体蛋白L37在前列腺癌中的表达及临床意义[J].天津医科大学学报,2015,21(05):401.
SHENG Bin,ZHANG Meng,MA Peng-de,et al.Expression of ribosomal protein L37 in prostate cancer and its clinical significance[J].Journal of Tianjin Medical University,2015,21(02):401.
[7]管明秀,周云丽,王 萌,等.TuM2-PK,tPSA,fPSA/tPSA和PSAD对PSA灰区前列腺癌诊断价值的比较[J].天津医科大学学报,2016,22(02):140.
GUAN Ming-xiu,ZHOU Yun-li,WANG-Meng,et al.Diagnostic implication of TuM2-PK, tPSA, fPSA/tPSA ratio and PSAD for prostate cancer in PSA gray area[J].Journal of Tianjin Medical University,2016,22(02):140.
[8]张一然,潘盼,连振鹏,等.磁共振扫描对经直肠超声引导前列腺穿刺活检的影响[J].天津医科大学学报,2017,23(02):99.
ZHANG Yi-ran,PAN Pan,LIAN Zhen-peng,et al.Effect of magnetic resonance imaging scan on the?transrectal ultrasound?prostate biopsy[J].Journal of Tianjin Medical University,2017,23(02):99.
[9]薄志强,孙桂江,王 丽,等.CtBP2异常表达对前列腺癌PC3细胞增殖效应影响的研究[J].天津医科大学学报,2017,23(02):103.
BO Zhi-qiang,SUNGui-jiang,WANG Li,et al.Effect of abnormal expression of CtBP2 on the proliferation of prostate cancer cell line PC3[J].Journal of Tianjin Medical University,2017,23(02):103.
[10]徐庆祝,牛远杰.Gleason 10分前列腺癌患者临床特点分析[J].天津医科大学学报,2017,23(04):361.
XU Qing-zhu,NIU Yuan-jie.Clinical and pathological research of prostate cancer with Gleason score 10[J].Journal of Tianjin Medical University,2017,23(02):361.